The SPINRAZA® study programme comprises multiple open-label and randomised controlled trials and an open-label extension study.1
Claire
age 19* Later-onset SMA
treated with SPINRAZA®
*Age at time of photo shoot.
References:
1. SPINRAZA® Summary of Product Characteristics.